{"data":{"id":"us-nv/nrs-635.086","jurisdiction":"us-nv","citation":"NRS 635.086","heading":"Training required for administration of certain neuromodulators related to Clostridium botulinum and dermal or soft tissue fillers by podiatric physician; proof of training; regulations.","body":"1. The Board shall adopt regulations prescribing the training that a podiatric physician must receive before injecting:\n(a) A neuromodulator that is derived from Clostridium botulinum;\n(b) A neuromodulator that is biosimilar to or the bioequivalent of a neuromodulator described in paragraph (a); or\n(c) Dermal or soft tissue fillers.\n2. A podiatric physician who has received the training prescribed pursuant to subsection 1 shall present proof of such training upon the request of a patient or any state or local governmental agency or agent thereof.\n3. As used in this section “dermal or soft tissue filler” has the meaning ascribed to it in NRS 629.086.","path":["TITLE 54 — PROFESSIONS, OCCUPATIONS AND BUSINESSES","CHAPTER 635 - PODIATRIC PHYSICIANS AND PODIATRY HYGIENISTS","LICENSES"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-635.html#NRS635Sec086","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:44Z","sha256":"bb6ee9200e245bcb0fd06d89edaebf461099e32949fd8308cd4c2919d3c6118f","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-635.085","next":"us-nv/nrs-635.087"},"notice":"GroundRules: Original legal text. Not legal advice."}